Preoperative (neoadjuvant) systemic treatment of breast cancer-Reference-Cited by-同舟云学术

Preoperative (neoadjuvant) systemic treatment of breast cancer

Published:2005-12 Issue:6 Volume:14 Page:576-581
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Kaufmann Manfred,von Minckwitz Gunter,Rody Achim

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference25 articles.

1. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

2. First report of the European cooperative trial in operable breast cancer (ECTO): effects of primary systemic therapy (PST) on local-regional disease;Gianni;Proc ASCO,2002

3. Preoperative chemotherapy in primary operable breast cancer: results from the European organization for research and treatment of cancer trial 10902;Van der Hage;J Clin Oncol,2001

4. Primary versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: preliminary results of a randomised trial;Scholl;Eur J Cancer,1994

5. Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study;Von Minckwitz;J Clin Oncol,2001

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European quality indicators developed by the European Commission Initiative on Breast Cancer: a first nationwide assessment for the Dutch setting;Breast Cancer Research and Treatment;2023-10-26

2. Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy;JAMA Oncology;2019-01-01

3. Anti-HER2 CD4+ T-Helper Type 1 Immune Response is Superior to Breast MRI for Assessing Response to Neoadjuvant Therapy in Patients with HER2-Positive Breast Cancer;Annals of Surgical Oncology;2016-11-08

4. A Prostate Cancer Patient’s 24 Year Continuing Journey from Diagnosis to Mentoring;Journal of Cancer Prevention & Current Research;2016-11-03

5. Role of Anti-HER-2 Therapies in the Neo-Adjuvant Setting: Is Complete Pathological Response a Solid Surrogate?;Reviews on Recent Clinical Trials;2015-07-14